Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Invesco Biotechnology & Genome ETF

PBEARCA

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$67.63

0.520.77%

At close: -

$65.50

-2.13-3.14%

After Hours: Jun 26, 8:00 AM EDT

News

Holdings Dividends Short Interest

Latest news for Invesco Biotechnology & Genome ETF (ARCA:PBE)

Invesco Biotechnology & Genome ETF (ARCA: PBE)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 13, 2023

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh

Wednesday, April 12, 2023

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh

Tuesday, April 11, 2023

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh

Thursday, April 06, 2023

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh

Thursday, March 16, 2023

US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh

Wednesday, March 01, 2023

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh

Monday, June 07, 2021

5 Top ETFs With Exposure To Biogen
Chris Katje

Monday, December 14, 2020

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
ETF Professor

Friday, September 25, 2020

3 Health Care ETFs Where Components Are Enduring Downgrades
ETF Professor

Tuesday, November 14, 2017

Biotech ETFs: What Lies Ahead?
Benzinga

Friday, October 06, 2017

Heaps Of Healthy Health Care ETFs
Benzinga

Monday, October 17, 2016

Exclusive: SunTrust Managing Director Goes Over Sarepta Therapeutics' Story
Benzinga

Thursday, October 13, 2016

Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy
Benzinga

Monday, December 08, 2014

3 Biotech ETFs Rally On Merger News
Benzinga

Wednesday, August 27, 2014

Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)
Benzinga

Tuesday, June 10, 2014

ETF Outlook For Tuesday, June 10, 2014 (IAT, FXE, PBE, HYHG, IDIX, MRK)
Benzinga

Sunday, February 16, 2014

Biotech And Natural Gas ETFs On A Roll
Benzinga

Wednesday, January 08, 2014

ETF Outlook for Wednesday, January 8, 2014 (ROBO, PBE, SMH, EUFN)
Benzinga

Wednesday, December 11, 2013

ETF Outlook for Wednesday, December 11, 2013 (IGN, PBE, EWA, XLF)
Benzinga

Thursday, September 05, 2013

Biotech Breakout Highlights Flawed ETF Thinking
Benzinga

Tuesday, June 18, 2013

Interesting Similarities Among 2013's Top-Performing ETFs
Benzinga

Thursday, April 11, 2013

Under The Hood: An Unheralded Biotech ETF
Benzinga

Monday, January 07, 2013

4 Health Care ETFs Your Broker Forgot to Mention
Benzinga

Monday, July 16, 2012

3 Unheralded ETFs Up More Than 10% in the Past 90 Days (PBE, TAGS)
Benzinga

Wednesday, June 27, 2012

Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)
Benzinga

Monday, May 21, 2012

The Definitive Biotech ETF Guide (IBB, XBI, FBT)
Benzinga

Thursday, February 23, 2012

Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)
Benzinga

Wednesday, July 20, 2011

Five Health Care ETFs Your Broker Forget To Mention
Benzinga

Thursday, March 10, 2011

Health Insurers Triple S&P 500 Returns
Benzinga

Wednesday, December 22, 2010

A Biotech ETF for Any Risk Level
Benzinga

Monday, December 06, 2010

ETFs For Biotech M&A Mania
Benzinga

Tuesday, March 09, 2010

Five Biotech ETFs, Which One Is Worth A Look?
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved